Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 AbGOPAL, Ajay K; PRESS, Oliver W; WILBUR, Shani M et al.Blood. 2008, Vol 112, Num 3, pp 830-835, issn 0006-4971, 6 p.Article

Anti-CD20 monoclonal antibodies: historical and future perspectivesLIM, Sean H; BEERS, Stephen A; FRENCH, Ruth R et al.Haematologica (Roma). 2010, Vol 95, Num 1, pp 135-143, issn 0390-6078, 9 p.Article

Anti-CD20 Antibody Therapy for B-Cell LymphomasMALONEY, David G.The New England journal of medicine. 2012, Vol 366, Num 21, pp 2008-2016, issn 0028-4793, 9 p.Article

Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibodyGOLDENBERG, David M; ROSSI, Edmund A; STEIN, Rhona et al.Blood. 2009, Vol 113, Num 5, pp 1062-1070, issn 0006-4971, 9 p.Article

Anti-CD20 en oncohématologie : Biothérapies = Anti-C020 in hematologic oncologyMILPIED, Noël.La Presse médicale (1983). 2009, Vol 38, Num 5, pp 788-798, issn 0755-4982, 11 p.Article

Is Splenectomy Necessary for Immune Thrombocytopenic Purpura? The Role of Rituximab in Patients With Corticosteroid Resistance in a Single-Center ExperienceCHENG ZHANG; LIU, Huan-Feng; CHEN, Xing-Hua et al.Clinical therapeutics. 2014, Vol 36, Num 3, pp 385-388, issn 0149-2918, 4 p.Article

Low-dose anti-CD20 veltuzumab given intravenously or subcutaneously is active in relapsed immune thrombocytopenia: a phase I studyLIEBMAN, Howard A; SALEH, Mansoor N; BUSSEL, James B et al.British journal of haematology. 2013, Vol 162, Num 5, pp 693-701, issn 0007-1048, 9 p.Article

Anti-CD20 monoclonal antibody therapy in multiple myelomaKAPOOR, Prashant; GREIPP, Patricia T; MORICE, William G et al.British journal of haematology. 2008, Vol 141, Num 2, pp 135-148, issn 0007-1048, 14 p.Article

Effector mechanisms of anti-CD20 monoclonal antibodies in B cell malignanciesOKROJ, Marcin; ÖSTERBORG, Anders; BLOM, Anna M et al.Cancer treatment reviews. 2013, Vol 39, Num 6, pp 632-639, issn 0305-7372, 8 p.Article

Anti-CD20 IgA can protect mice against lymphoma development: evaluation of the direct impact of IgA and cytotoxic effector recruitment on CD20 target cellsPASCAL, Virginie; LAFFLEUR, Brice; COGNE, Michel et al.Haematologica (Roma). 2012, Vol 97, Num 11, pp 1686-1694, issn 0390-6078, 9 p.Article

CD40 stimulation sensitizes CLL cells to rituximab-induced cell deathJAK, M; VAN BOCHOVE, G. G. W; VAN LIER, R. A. W et al.Leukemia. 2011, Vol 25, Num 6, pp 968-978, issn 0887-6924, 11 p.Article

Subcutaneous injections of low-dose veltuzumab (humanized anti-CD20 antibody) are safe and active in patients with indolent non-Hodgkin's lymphomaNEGREA, George O; ELSTROM, Rebecca; ALLEN, Steven L et al.Haematologica (Roma). 2011, Vol 96, Num 4, pp 567-573, issn 0390-6078, 7 p.Article

Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infectionBROWNE, Sarah K; ZAMAN, Rifat; FREEMAN, Alexandra F et al.Blood. 2012, Vol 119, Num 17, pp 3933-3939, issn 0006-4971, 7 p.Article

Ofatumumab: A Novel Anti-CD20 Monoclonal Antibody for Treatment of Refractory Chronic Lymphocytic LeukemiaNIGHTINGALE, Ginah.The Annals of pharmacotherapy. 2011, Vol 45, Num 10, pp 1248-1255, issn 1060-0280, 8 p.Article

Acquired hemophilia A: three different presentations of the same diseaseDEL CAMPO, Raquel; BARGAY, Juan; CLADERA, Antonia et al.Blood coagulation & fibrinolysis. 2010, Vol 21, Num 2, pp 188-191, issn 0957-5235, 4 p.Article

Type II (tositumomab) anti-CD20 monoclonal antibody out performs type I (rituximab-like) reagents in B-cell depletion regardless of complement activationBEERS, Stephen A; CHAN, Claude H. T; JAMES, Sonya et al.Blood. 2008, Vol 112, Num 10, pp 4170-4177, issn 0006-4971, 8 p.Article

Lineage determination of CD20- B-cell neoplasms : An immunohistochemical studyCHU, Peiguo G; LOERA, Sofia; QIN HUANG et al.American journal of clinical pathology. 2006, Vol 126, Num 4, pp 534-544, issn 0002-9173, 11 p.Article

Caractéristiques et traitement des anémies hémolytiques auto-immunes et du syndrome d'Evans de l'adulte = Characteristics and management of autoimmune haemolytic anemia and Evans'syndrome in adultsMICHEL, M.La Revue de médecine interne (Paris). 2008, Vol 29, pp 54-60, issn 0248-8663, 7 p., HS1Conference Paper

Imaging and Therapy with Rituximab Anti-CD20 Immunotherapy in an Animal Model of Central Nervous System LymphomaMULDOON, Leslie L; LEWIN, Seth J; DOSA, Edit et al.Clinical cancer research (Print). 2011, Vol 17, Num 8, pp 2207-2215, issn 1078-0432, 9 p.Article

Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulinsSHIMANOVICH, I; NITSCHKE, M; ROSE, C et al.British journal of dermatology (1951). 2008, Vol 158, Num 2, pp 382-388, issn 0007-0963, 7 p.Article

Intratumoral But Not Systemic Delivery of CpG Oligodeoxynucleotide Augments the Efficacy of Anti-CD20 Monoclonal Antibody Therapy Against B Cell LymphomaBETTING, David J; YAMADA, Reiko E; KAFI, Kamran et al.Journal of immunotherapy (1997). 2009, Vol 32, Num 6, pp 622-631, issn 1524-9557, 10 p.Article

A case of non-Hodgkin's lymphoma-associated pemphigus foliaceus and use of rituximab for treatmentPRODANOVIC, Edward M; KORMAN, Neil J.Journal of dermatological treatment. 2008, Vol 19, Num 6, pp 368-370, issn 0954-6634, 3 p.Article

Radiation Therapy with Tositumomab (B1) Anti-CD20 Monoclonal Antibody Initiates Extracellular Signal-Regulated Kinase/ Mitogen-Activated Protein Kinase-Dependent Cell Death that Overcomes Resistance to ApoptosisIVANOV, Andrey; KRYSOV, Sergei; CRAGG, Mark S et al.Clinical cancer research (Print). 2008, Vol 14, Num 15, pp 4925-4934, issn 1078-0432, 10 p.Article

Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cellsPATZ, Michaela; ISAEVA, Polina; FORCOB, Nche et al.British journal of haematology. 2011, Vol 152, Num 3, pp 295-306, issn 0007-1048, 12 p.Article

A comparison of 4 radionuclides conjugated to antibodies for single-cell killMICHEL, Rosana B; BRECHBIEL, Martin W; MATTES, M. Jules et al.The Journal of nuclear medicine (1978). 2003, Vol 44, Num 4, pp 632-640, issn 0161-5505, 9 p.Article